Advertisement

Tuning of n- and p-Type Reduced Graphene Oxide Transistors with the Same Molecular Backbone.

02:51 EDT 19th May 2013 | BioPortfolio

Summary of "Tuning of n- and p-Type Reduced Graphene Oxide Transistors with the Same Molecular Backbone."

Play the field: A field-effect transistor using reduced graphene oxides was prepared through the reduction of graphene oxides connected between two electrodes. The use of pyrene with an electron-withdrawing group and an electron-donating group showed the p- and n-doping effects, respectively, while the pyrene backbone with no electron-withdrawing or -donating groups showed no doping effect.

Affiliation

NCRI, Center for Smart Molecular Memory, Department of Chemistry, Sungkyunkwan University, Suwon 440-746 (Republic of Korea), Fax: (+82) 31-299-5934.

Journal Details

This article was published in the following journal.

Name: Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Pages: 5155-9

Links

Medical and Biotech [MESH] Definitions

Nitric Oxide Synthase Type Iii

A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in ENDOTHELIAL CELLS.

Nitric Oxide Synthase Type I

A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in NERVE TISSUE.

Nitric Oxide Synthase Type Ii

A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.

Hyperlipoproteinemia Type V

A severe type of hyperlipidemia, sometimes familial, that it is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .

Nitric Oxide

A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.

PubMed Articles [ 16363 Associated PubMed Articles listed on BioPortfolio]

Dual n-type doped reduced graphene oxide field effect transistors controlled by semiconductor nanocrystals.

Here, we demonstrate a rapid and simple method for doping a reduced graphene oxide (rGO) field effect transistor (FET) with nanocrystals to produce dual n-type behavior with light and bias voltage. Th...

n-Type Reduced Graphene Oxide Field-Effect Transistors (FETs) from Photoactive Metal Oxides.

Graphene is of considerable interest as a next-generation semiconductor material to serve as a possible substitute for silicon. For real device applications with complete circuits, effective n-type gr...

Ultrafast room temperature NH(3) sensing with positively gated reduced graphene oxide field-effect transistors.

Reduced graphene oxide (R-GO) under a positive gate potential (n-type conductance) exhibits an instantaneous response and fast recovery for NH(3) sensing, far superior to the performance in p-mode at...

Wafer-Scale Patterning of Reduced Graphene Oxide Electrodes by Transfer-and-Reverse Stamping for High Performance OFETs.

A wafer-scale patterning method for solution-processed graphene electrodes, named the transfer-and-reverse stamping method, is universally applicable for fabricating source/drain electrodes of n- and...

Synthesis of Highly n-Type Graphene by Using an Ionic Liquid.

n-Type graphene: A new, easy, and cheap method to produce n-type reduced graphene oxide was developed by synthesizing a partially reduced intermediate containing nitrogen (PrGO-IL, see scheme) by trea...

Clinical Trials [ 2958 Associated Clinical Trials listed on BioPortfolio]

N-Acetylcysteine and Arginine Administration in Diabetic Patients

It has been demonstrated that the nitric oxide production is reduced in type 2 diabetic patients and that cardiovascular complications represent 80% of the causes of death in these patient...

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide preven...

Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abuser...

Nitric Oxide and the Autonomic Nervous System

The amount of blood flowing to the different parts of the body is regulated by the autonomic (automatic) nerves and by local factors produced by the blood vessels. Nitric oxide (NO) is on...

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abuser...

Search BioPortfolio: